Exact Mass: 590.4311

Exact Mass Matches: 590.4311

Found 500 metabolites which its exact mass value is equals to given mass value 590.4311, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ubiquinone 6

2-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

C39H58O4 (590.4335)


Ubiquinone-6 is a member of the chemical class known as Polyprenylbenzoquinones. These are compounds containing a polyisoprene chain attached to a quinone at the second ring position. Ubiquione-6 has just 6 isoprene units. Normally in humans it has 10. Ubiquinone-6 is an intermediate in the synthesis of Ubiquionone 10. It is an endogenouse compound but it has also been isolated from foods containing bakers yeast. Ubiquionone 10 (CoQ10) is involved in cellular respiration. It is fat-soluble and is therefore mobile in cellular membranes; it plays a unique role in the electron transport chain (ETC). In the inner bacterial membrane, electrons from NADH and succinate pass through the ETC to the oxygen, which is then reduced to water. The transfer of electrons through ETC results in the pumping of H+ across the membrane creating a proton gradient across the membrane, which is used by ATP synthase (located on the membrane) to generate ATP. Isolated from bakers yeast (Saccharomyces cerevisiae)

   

Saringosterol 3-glucoside

2-({14-[5-hydroxy-5-(propan-2-yl)hept-6-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)


Saringosterol 3-glucoside is found in pulses. Saringosterol 3-glucoside is a constituent of immature French bean seeds (Phaseolus vulgaris)

   

Melilotoside A

2-{[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


Melilotoside A is found in herbs and spices. Melilotoside A is a constituent of Melilotus albus (white melilot). Constituent of Melilotus albus (white melilot). Melilotoside A is found in herbs and spices and pulses.

   

Feruloyl-beta-sitosterol

(1S,2R,5S,10S,11S,14R,15R)-14-[(2R,5R)-5-Ethyl-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid

C39H58O4 (590.4335)


Feruloyl-beta-sitosterol is found in cereals and cereal products. Feruloyl-beta-sitosterol is isolated from rice bran oil (Oryza sativa).

   

Hebevinoside IX

2-{[9,13-dihydroxy-1,6,6,11,15-pentamethyl-14-(6-methylhept-5-en-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


Toxic constituent of the toxic mushroom Hebeloma vinosophyllum. Hebevinoside IX is found in mushrooms. Hebevinoside IX is found in mushrooms. Toxic constituent of the toxic mushroom Hebeloma vinosophyllu

   

DG(12:0/PGJ2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl dodecanoic acid

C35H58O7 (590.4182)


DG(12:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propan-2-yl dodecanoic acid

C35H58O7 (590.4182)


DG(PGJ2/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/PGJ2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl dodecanoic acid

C35H58O7 (590.4182)


DG(12:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/0:0/12:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl dodecanoic acid

C35H58O7 (590.4182)


DG(PGJ2/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl tridecanoic acid

C36H62O6 (590.4546)


DG(13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl tridecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl tridecanoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/13:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl tridecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl tridecanoic acid

C36H62O6 (590.4546)


DG(13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl tridecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,11Z,14Z)-O(8,9)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl tridecanoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/13:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl tridecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl tridecanoic acid

C36H62O6 (590.4546)


DG(13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/13:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl tridecanoic acid

C36H62O6 (590.4546)


DG(20:3(8Z,11Z,14Z)-O(5,6)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl tridecanoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/13:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl tridecanoic acid

C36H62O6 (590.4546)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5Z,8Z,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-13:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/a-13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,11Z,14Z)-O(8,9)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-13:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/a-13:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(8Z,11Z,14Z)-O(5,6)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-13:0/0:0)

(2S)-3-hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(a-13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/PGJ2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H58O7 (590.4182)


DG(i-12:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/i-12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propan-2-yl 10-methylundecanoic acid

C35H58O7 (590.4182)


DG(PGJ2/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/PGJ2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H58O7 (590.4182)


DG(i-12:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/0:0/i-12:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H58O7 (590.4182)


DG(PGJ2/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-13:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-13:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,11Z,14Z)-O(8,9)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-13:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-13:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(8Z,11Z,14Z)-O(5,6)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 11-methyldodecanoic acid

C36H62O6 (590.4546)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-13:0/0:0)

(2S)-3-hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-13:0)

(2S)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C36H62O6 (590.4546)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(i-13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C36H62O6 (590.4546)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Schottenol 3-ferulate

(2S,5S,7S,14R,15R)-14-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-en-5-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C39H58O4 (590.4335)


Schottenol 3-ferulate is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Schottenol 3-ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Schottenol 3-ferulate can be found in corn, which makes schottenol 3-ferulate a potential biomarker for the consumption of this food product.

   

Buxmicrophylline F

Buxmicrophylline F

C37H54N2O4 (590.4083)


   

Staphimine

Staphimine

C41H54N2O (590.4236)


   

Daucosterol

Daucosterol

C36H62O6 (590.4546)


   

3beta-O-cis-p-coumaroylmonogynol A

3beta-O-cis-p-coumaroylmonogynol A

C39H58O4 (590.4335)


   

3alpha-acetoxyl-21S-methoxy-25-ethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S-diol|chisopanin J

3alpha-acetoxyl-21S-methoxy-25-ethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S-diol|chisopanin J

C35H58O7 (590.4182)


   

7-oxositosteryl-beta-D-glucopyranoside|7-Oxositosteryl-??-O-glucopyranoside

7-oxositosteryl-beta-D-glucopyranoside|7-Oxositosteryl-??-O-glucopyranoside

C35H58O7 (590.4182)


   

FT-0674605

FT-0674605

C35H58O7 (590.4182)


   

21-(3-15399-42-5Methylbutanoyl)---12-Oleanene-3,16,21,22,23,28-hexol|21-(3-Methylbutanoyl) -(3beta,16alpha,21beta,22alpha)-12-Oleanene-3,16,21,22,23,28-hexol

21-(3-15399-42-5Methylbutanoyl)---12-Oleanene-3,16,21,22,23,28-hexol|21-(3-Methylbutanoyl) -(3beta,16alpha,21beta,22alpha)-12-Oleanene-3,16,21,22,23,28-hexol

C35H58O7 (590.4182)


   

dammarenediol II 3-O-p-coumarate

dammarenediol II 3-O-p-coumarate

C39H58O4 (590.4335)


   

beta-sitosteryl-beta-D-glucoside

beta-sitosteryl-beta-D-glucoside

C36H62O6 (590.4546)


   

Giganteumgenin H|Giganteumgenin K

Giganteumgenin H|Giganteumgenin K

C35H58O7 (590.4182)


   

Giganteumgenin G

Giganteumgenin G

C35H58O7 (590.4182)


   

Alloxanthin

Alloxanthin

C42H54O2 (590.4124)


   

Giganteumgenin K

Giganteumgenin K

C35H58O7 (590.4182)


   

beta-sitosteryl-beta-D-galactoside

beta-sitosteryl-beta-D-galactoside

C36H62O6 (590.4546)


   

(3beta,16beta,21beta,22alpha)-3,16,22,23,28-pentahydroxyolean-12-en-21-yl (2S)-2-methylbutanoate

(3beta,16beta,21beta,22alpha)-3,16,22,23,28-pentahydroxyolean-12-en-21-yl (2S)-2-methylbutanoate

C35H58O7 (590.4182)


   

beta-sitosterol 3-O-beta-D-glucopyranoside

beta-sitosterol 3-O-beta-D-glucopyranoside

C36H62O6 (590.4546)


   

chisopanin N

chisopanin N

C35H58O7 (590.4182)


   

3-beta,15-alpha,23,28-tetrahydroxyolean-12-en-3-O-alpha-L-arabinofuranoside

3-beta,15-alpha,23,28-tetrahydroxyolean-12-en-3-O-alpha-L-arabinofuranoside

C35H58O7 (590.4182)


   

22alpha-angeloyloxy-3beta,15alpha,16alpha,28-tetrahydroxyolean-12-ene

22alpha-angeloyloxy-3beta,15alpha,16alpha,28-tetrahydroxyolean-12-ene

C35H58O7 (590.4182)


   

feroniellide D

feroniellide D

C35H58O7 (590.4182)


   

C35H58O7

C35H58O7 (590.4182)


   

Delta7-sitosterol trans-ferulate|schottenol ferulate

Delta7-sitosterol trans-ferulate|schottenol ferulate

C39H58O4 (590.4335)


   

21alpha-hydroxyserrat-14-en-3beta-yl p-dihydrocoumarate|21??-Hydroxyserrat-14-en-3??-yl p-dihydrocoumarate

21alpha-hydroxyserrat-14-en-3beta-yl p-dihydrocoumarate|21??-Hydroxyserrat-14-en-3??-yl p-dihydrocoumarate

C39H58O4 (590.4335)


   

beta-sitosteryl-beta-D-galactosidase

beta-sitosteryl-beta-D-galactosidase

C36H62O6 (590.4546)


   

(22R)-stigmasta-7,9(11)-dien-22alpha-ol-3beta-O-beta-D-galactopyranoside

(22R)-stigmasta-7,9(11)-dien-22alpha-ol-3beta-O-beta-D-galactopyranoside

C35H58O7 (590.4182)


   

C43H58O

C43H58O (590.4487)


   

beta-sitosteryl glucuronate|stigmast-5-en-3beta-yl glucuronate

beta-sitosteryl glucuronate|stigmast-5-en-3beta-yl glucuronate

C35H58O7 (590.4182)


   

Descladinose Azithromycin

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10,13-tetrahydroxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one

C30H58N2O9 (590.4142)


   

DescladinoseAzithromycin

DescladinoseAzithromycin

C30H58N2O9 (590.4142)


   

PA(P-16:0/13:0)

1-(1Z-hexadecenyl)-2-tridecanoyl-glycero-3-phosphate

C32H63O7P (590.4311)


   

Saringosterol 3-glucoside

2-({14-[5-hydroxy-5-(propan-2-yl)hept-6-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)


   

Hebevinoside IX

2-{[9,13-dihydroxy-1,6,6,11,15-pentamethyl-14-(6-methylhept-5-en-2-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


   

Sitosterol ferulate

(1S,2R,5S,10S,11S,14R,15R)-14-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C39H58O4 (590.4335)


   

Melilotoside A

2-{[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


   

PA O-29:1

1-(1Z-hexadecenyl)-2-tridecanoyl-glycero-3-phosphate

C32H63O7P (590.4311)


   

Coenzyme Q6

ubiquinone-6

C39H58O4 (590.4335)


   

CHOLESTERYL 9-ANTHRACENECARBOXYLATE

CHOLESTERYL 9-ANTHRACENECARBOXYLATE

C42H54O2 (590.4124)


   

Titanium(III) chloride-aluminum chloride

Titanium(III) chloride-aluminum chloride

AlCl12Ti3 (590.4516)


   

N-lauroyl-D-erythro-sphingosyl phosphoethanolamine (C17 base)

2-aminoethyl [(E,2S,3R)-2-(dodecanoylamino)-3-hydroxyheptadec-4-enyl] hydrogen phosphate

C31H63N2O6P (590.4424)


   

Schottenol ferulate

Schottenol ferulate

C39H58O4 (590.4335)


   

DG(12:0/PGJ2/0:0)

DG(12:0/PGJ2/0:0)

C35H58O7 (590.4182)


   

DG(PGJ2/12:0/0:0)

DG(PGJ2/12:0/0:0)

C35H58O7 (590.4182)


   

DG(12:0/0:0/PGJ2)

DG(12:0/0:0/PGJ2)

C35H58O7 (590.4182)


   

DG(PGJ2/0:0/12:0)

DG(PGJ2/0:0/12:0)

C35H58O7 (590.4182)


   

DG(i-12:0/PGJ2/0:0)

DG(i-12:0/PGJ2/0:0)

C35H58O7 (590.4182)


   

DG(PGJ2/i-12:0/0:0)

DG(PGJ2/i-12:0/0:0)

C35H58O7 (590.4182)


   

DG(i-12:0/0:0/PGJ2)

DG(i-12:0/0:0/PGJ2)

C35H58O7 (590.4182)


   

DG(PGJ2/0:0/i-12:0)

DG(PGJ2/0:0/i-12:0)

C35H58O7 (590.4182)


   

DG(13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C36H62O6 (590.4546)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/13:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C36H62O6 (590.4546)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/13:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C36H62O6 (590.4546)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/13:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C36H62O6 (590.4546)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/13:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C36H62O6 (590.4546)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/13:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C36H62O6 (590.4546)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/13:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C36H62O6 (590.4546)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/13:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C36H62O6 (590.4546)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/13:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/13:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/13:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C36H62O6 (590.4546)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/13:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/13:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/13:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/13:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/13:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/13:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/13:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/13:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/13:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/13:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/13:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/13:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/13:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C36H62O6 (590.4546)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/13:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/13:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/13:0/0:0)

C36H62O6 (590.4546)


   

DG(13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C36H62O6 (590.4546)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/13:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/13:0)

C36H62O6 (590.4546)


   

DG(a-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(a-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C36H62O6 (590.4546)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-13:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-13:0/0:0)

C36H62O6 (590.4546)


   

DG(a-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(a-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C36H62O6 (590.4546)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-13:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-13:0)

C36H62O6 (590.4546)


   

DG(a-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(a-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C36H62O6 (590.4546)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-13:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-13:0/0:0)

C36H62O6 (590.4546)


   

DG(a-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(a-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C36H62O6 (590.4546)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-13:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-13:0)

C36H62O6 (590.4546)


   

DG(a-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(a-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C36H62O6 (590.4546)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/a-13:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/a-13:0/0:0)

C36H62O6 (590.4546)


   

DG(a-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(a-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C36H62O6 (590.4546)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-13:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-13:0)

C36H62O6 (590.4546)


   

DG(a-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(a-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C36H62O6 (590.4546)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/a-13:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/a-13:0/0:0)

C36H62O6 (590.4546)


   

DG(a-13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(a-13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C36H62O6 (590.4546)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-13:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-13:0)

C36H62O6 (590.4546)


   

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-13:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-13:0/0:0)

C36H62O6 (590.4546)


   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C36H62O6 (590.4546)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-13:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-13:0)

C36H62O6 (590.4546)


   

DG(a-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(a-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C36H62O6 (590.4546)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-13:0/0:0)

C36H62O6 (590.4546)


   

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C36H62O6 (590.4546)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-13:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-13:0)

C36H62O6 (590.4546)


   

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C36H62O6 (590.4546)


   

N-lauroyl-D-D-erythro-heptadecasphingosyl phosphoethanolamine

N-lauroyl-D-D-erythro-heptadecasphingosyl phosphoethanolamine

C31H63N2O6P (590.4424)


   

(2S,3R,4S,5S)-2-[[(3S,4S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]oxane-3,4,5-triol

(2S,3R,4S,5S)-2-[[(3S,4S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]oxane-3,4,5-triol

C35H58O7 (590.4182)


   

cholesteryl 6-O-acetyl-beta-D-galactoside

cholesteryl 6-O-acetyl-beta-D-galactoside

C35H58O7 (590.4182)


A cholesteryl 6-O-acyl-beta-D-galactoside having acetyl as the 6-O-acyl group.

   

(2S,3R,4S,5R)-2-[[(9R,10R,13R,14S,16R,17R)-7,16-dihydroxy-4,4,9,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

(2S,3R,4S,5R)-2-[[(9R,10R,13R,14S,16R,17R)-7,16-dihydroxy-4,4,9,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

C35H58O7 (590.4182)


   

Mgdg O-19:0_4:0

Mgdg O-19:0_4:0

C32H62O9 (590.4394)


   

Mgdg O-20:0_3:0

Mgdg O-20:0_3:0

C32H62O9 (590.4394)


   

Mgdg O-17:0_6:0

Mgdg O-17:0_6:0

C32H62O9 (590.4394)


   

Mgdg O-14:0_9:0

Mgdg O-14:0_9:0

C32H62O9 (590.4394)


   

Mgdg O-9:0_14:0

Mgdg O-9:0_14:0

C32H62O9 (590.4394)


   

Mgdg O-21:0_2:0

Mgdg O-21:0_2:0

C32H62O9 (590.4394)


   

Mgdg O-8:0_15:0

Mgdg O-8:0_15:0

C32H62O9 (590.4394)


   

Mgdg O-16:0_7:0

Mgdg O-16:0_7:0

C32H62O9 (590.4394)


   

Mgdg O-18:0_5:0

Mgdg O-18:0_5:0

C32H62O9 (590.4394)


   

Mgdg O-15:0_8:0

Mgdg O-15:0_8:0

C32H62O9 (590.4394)


   

Mgdg O-11:0_12:0

Mgdg O-11:0_12:0

C32H62O9 (590.4394)


   

Mgdg O-10:0_13:0

Mgdg O-10:0_13:0

C32H62O9 (590.4394)


   

Mgdg O-12:0_11:0

Mgdg O-12:0_11:0

C32H62O9 (590.4394)


   

Mgdg O-13:0_10:0

Mgdg O-13:0_10:0

C32H62O9 (590.4394)


   

PE-Cer 12:0;2O/17:1

PE-Cer 12:0;2O/17:1

C31H63N2O6P (590.4424)


   

PE-Cer 13:0;2O/16:1

PE-Cer 13:0;2O/16:1

C31H63N2O6P (590.4424)


   

PE-Cer 14:0;2O/15:1

PE-Cer 14:0;2O/15:1

C31H63N2O6P (590.4424)


   

PE-Cer 14:1;2O/15:0

PE-Cer 14:1;2O/15:0

C31H63N2O6P (590.4424)


   

PE-Cer 16:0;2O/13:1

PE-Cer 16:0;2O/13:1

C31H63N2O6P (590.4424)


   

PE-Cer 12:1;2O/17:0

PE-Cer 12:1;2O/17:0

C31H63N2O6P (590.4424)


   

PE-Cer 13:1;2O/16:0

PE-Cer 13:1;2O/16:0

C31H63N2O6P (590.4424)


   

PE-Cer 15:0;2O/14:1

PE-Cer 15:0;2O/14:1

C31H63N2O6P (590.4424)


   

PE-Cer 15:1;2O/14:0

PE-Cer 15:1;2O/14:0

C31H63N2O6P (590.4424)


   

PE-Cer 16:1;2O/13:0

PE-Cer 16:1;2O/13:0

C31H63N2O6P (590.4424)


   

[(E)-3-hydroxy-2-(pentanoylamino)henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentanoylamino)henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-2-(hexanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-2-(heptanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C39H58O4 (590.4335)


   

[(E)-2-acetamido-3-hydroxytetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-acetamido-3-hydroxytetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-3-hydroxy-2-(octanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(octanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-2-(heptadecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptadecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-3-hydroxy-2-(propanoylamino)tricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(propanoylamino)tricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-3-hydroxy-2-(octadecanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(octadecanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-3-hydroxy-2-(nonanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(nonanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-2-(butanoylamino)-3-hydroxydocos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(butanoylamino)-3-hydroxydocos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-2-(hexadecanoylamino)-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexadecanoylamino)-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-3-hydroxy-2-(undecanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(undecanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-3-hydroxy-2-(tridecanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tridecanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-2-(decanoylamino)-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(decanoylamino)-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-3-hydroxy-2-(tetradecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tetradecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-3-hydroxy-2-(pentadecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentadecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E)-2-(dodecanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(dodecanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

N-(dodecanoyl)-4E-tetradecasphingenine-1-phosphocholine

N-(dodecanoyl)-4E-tetradecasphingenine-1-phosphocholine

C31H63N2O6P (590.4424)


   

N-(decanoyl)-4E-hexadecasphingenine-1-phosphocholine

N-(decanoyl)-4E-hexadecasphingenine-1-phosphocholine

C31H63N2O6P (590.4424)


   

[1-carboxy-3-[2-hydroxy-3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-hydroxy-3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO6+ (590.442)


   

[(E,2S,3R)-2-(dodecanoylamino)-3-hydroxytetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-2-(dodecanoylamino)-3-hydroxytetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

[(E,2S,3R)-2-(decanoylamino)-3-hydroxyhexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-2-(decanoylamino)-3-hydroxyhexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)


   

2-[hydroxy-[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)


   

2-[[2-heptanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-heptanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)


   

2-[[2-butanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-butanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)


   

2-[[2-acetyloxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-acetyloxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)


   

2-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)


   

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)


   

beta-sitosteryl ferulate

beta-sitosteryl ferulate

C39H58O4 (590.4335)


   

ubiquinone-6

ubiquinone-6

C39H58O4 (590.4335)


A ubiquinone compound having a (2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl substituent at position 2.

   

Co(0:0)

Co(0:0(6Q))

C39H58O4 (590.4335)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

FAHFA 13:2/O-26:7

FAHFA 13:2/O-26:7

C39H58O4 (590.4335)


   

FAHFA 13:3/O-26:6

FAHFA 13:3/O-26:6

C39H58O4 (590.4335)


   

FAHFA 13:4/O-26:5

FAHFA 13:4/O-26:5

C39H58O4 (590.4335)


   

FAHFA 14:2/O-25:7

FAHFA 14:2/O-25:7

C39H58O4 (590.4335)


   

FAHFA 14:3/O-25:6

FAHFA 14:3/O-25:6

C39H58O4 (590.4335)


   

FAHFA 14:4/O-25:5

FAHFA 14:4/O-25:5

C39H58O4 (590.4335)


   

FAHFA 15:2/O-24:7

FAHFA 15:2/O-24:7

C39H58O4 (590.4335)


   

FAHFA 15:3/O-24:6

FAHFA 15:3/O-24:6

C39H58O4 (590.4335)


   

FAHFA 15:4/O-24:5

FAHFA 15:4/O-24:5

C39H58O4 (590.4335)


   

FAHFA 15:5/O-24:4

FAHFA 15:5/O-24:4

C39H58O4 (590.4335)


   

FAHFA 16:2/O-23:7

FAHFA 16:2/O-23:7

C39H58O4 (590.4335)


   

FAHFA 16:3/O-23:6

FAHFA 16:3/O-23:6

C39H58O4 (590.4335)


   

FAHFA 16:4/O-23:5

FAHFA 16:4/O-23:5

C39H58O4 (590.4335)


   

FAHFA 16:5/O-23:4

FAHFA 16:5/O-23:4

C39H58O4 (590.4335)


   

FAHFA 17:2/O-22:7

FAHFA 17:2/O-22:7

C39H58O4 (590.4335)


   

FAHFA 17:3/O-22:6

FAHFA 17:3/O-22:6

C39H58O4 (590.4335)


   

FAHFA 17:4/O-22:5

FAHFA 17:4/O-22:5

C39H58O4 (590.4335)


   

FAHFA 17:5/O-22:4

FAHFA 17:5/O-22:4

C39H58O4 (590.4335)


   

FAHFA 18:2/O-21:7

FAHFA 18:2/O-21:7

C39H58O4 (590.4335)


   

FAHFA 18:3/O-21:6

FAHFA 18:3/O-21:6

C39H58O4 (590.4335)


   

FAHFA 18:4/O-21:5

FAHFA 18:4/O-21:5

C39H58O4 (590.4335)


   

FAHFA 18:5/O-21:4

FAHFA 18:5/O-21:4

C39H58O4 (590.4335)


   

FAHFA 18:6/O-21:3

FAHFA 18:6/O-21:3

C39H58O4 (590.4335)


   

FAHFA 19:3/O-20:6

FAHFA 19:3/O-20:6

C39H58O4 (590.4335)


   

FAHFA 19:4/O-20:5

FAHFA 19:4/O-20:5

C39H58O4 (590.4335)


   

FAHFA 19:5/O-20:4

FAHFA 19:5/O-20:4

C39H58O4 (590.4335)


   

FAHFA 19:6/O-20:3

FAHFA 19:6/O-20:3

C39H58O4 (590.4335)


   

FAHFA 20:3/O-19:6

FAHFA 20:3/O-19:6

C39H58O4 (590.4335)


   

FAHFA 20:4/O-19:5

FAHFA 20:4/O-19:5

C39H58O4 (590.4335)


   

FAHFA 20:5/O-19:4

FAHFA 20:5/O-19:4

C39H58O4 (590.4335)


   

FAHFA 20:6/O-19:3

FAHFA 20:6/O-19:3

C39H58O4 (590.4335)


   

FAHFA 21:3/O-18:6

FAHFA 21:3/O-18:6

C39H58O4 (590.4335)


   

FAHFA 21:4/O-18:5

FAHFA 21:4/O-18:5

C39H58O4 (590.4335)


   

FAHFA 21:5/O-18:4

FAHFA 21:5/O-18:4

C39H58O4 (590.4335)


   

FAHFA 21:6/O-18:3

FAHFA 21:6/O-18:3

C39H58O4 (590.4335)


   

FAHFA 21:7/O-18:2

FAHFA 21:7/O-18:2

C39H58O4 (590.4335)


   

FAHFA 22:4/O-17:5

FAHFA 22:4/O-17:5

C39H58O4 (590.4335)


   

FAHFA 22:5/O-17:4

FAHFA 22:5/O-17:4

C39H58O4 (590.4335)


   

FAHFA 22:6/O-17:3

FAHFA 22:6/O-17:3

C39H58O4 (590.4335)


   

FAHFA 22:7/O-17:2

FAHFA 22:7/O-17:2

C39H58O4 (590.4335)


   

FAHFA 23:4/O-16:5

FAHFA 23:4/O-16:5

C39H58O4 (590.4335)


   

FAHFA 23:5/O-16:4

FAHFA 23:5/O-16:4

C39H58O4 (590.4335)


   

FAHFA 23:6/O-16:3

FAHFA 23:6/O-16:3

C39H58O4 (590.4335)


   

FAHFA 23:7/O-16:2

FAHFA 23:7/O-16:2

C39H58O4 (590.4335)


   

FAHFA 24:4/O-15:5

FAHFA 24:4/O-15:5

C39H58O4 (590.4335)


   

FAHFA 24:5/O-15:4

FAHFA 24:5/O-15:4

C39H58O4 (590.4335)


   

FAHFA 24:6/O-15:3

FAHFA 24:6/O-15:3

C39H58O4 (590.4335)


   

FAHFA 24:7/O-15:2

FAHFA 24:7/O-15:2

C39H58O4 (590.4335)


   

FAHFA 25:5/O-14:4

FAHFA 25:5/O-14:4

C39H58O4 (590.4335)


   

FAHFA 25:6/O-14:3

FAHFA 25:6/O-14:3

C39H58O4 (590.4335)


   

FAHFA 25:7/O-14:2

FAHFA 25:7/O-14:2

C39H58O4 (590.4335)


   

FAHFA 26:5/O-13:4

FAHFA 26:5/O-13:4

C39H58O4 (590.4335)


   

FAHFA 26:6/O-13:3

FAHFA 26:6/O-13:3

C39H58O4 (590.4335)


   

FAHFA 26:7/O-13:2

FAHFA 26:7/O-13:2

C39H58O4 (590.4335)


   

FAHFA 39:9;O

FAHFA 39:9;O

C39H58O4 (590.4335)


   

MGDG O-23:0

MGDG O-23:0

C32H62O9 (590.4394)


   

MGMG 23:0

MGMG 23:0

C32H62O9 (590.4394)


   

PA O-14:0/15:1

PA O-14:0/15:1

C32H63O7P (590.4311)


   

PA O-14:1/15:0

PA O-14:1/15:0

C32H63O7P (590.4311)


   

PA O-16:1/13:0

PA O-16:1/13:0

C32H63O7P (590.4311)


   

PA O-18:1/11:0

PA O-18:1/11:0

C32H63O7P (590.4311)


   

PA P-14:0/15:0

PA P-14:0/15:0

C32H63O7P (590.4311)


   

PA P-14:0/15:0 or PA O-14:1/15:0

PA P-14:0/15:0 or PA O-14:1/15:0

C32H63O7P (590.4311)


   

PA P-16:0/13:0

PA P-16:0/13:0

C32H63O7P (590.4311)


   

PA P-16:0/13:0 or PA O-16:1/13:0

PA P-16:0/13:0 or PA O-16:1/13:0

C32H63O7P (590.4311)


   

PA P-18:0/11:0

PA P-18:0/11:0

C32H63O7P (590.4311)


   

PA P-18:0/11:0 or PA O-18:1/11:0

PA P-18:0/11:0 or PA O-18:1/11:0

C32H63O7P (590.4311)


   

PA P-29:0

PA P-29:0

C32H63O7P (590.4311)


   

PA P-29:0 or PA O-29:1

PA P-29:0 or PA O-29:1

C32H63O7P (590.4311)


   

LPEth 27:1

LPEth 27:1

C32H63O7P (590.4311)


   

LPM 28:1

LPM 28:1

C32H63O7P (590.4311)


   

CerPE 14:0;O2/15:1

CerPE 14:0;O2/15:1

C31H63N2O6P (590.4424)


   

CerPE 14:1;O2/15:0

CerPE 14:1;O2/15:0

C31H63N2O6P (590.4424)


   

CerPE 15:0;O2/14:1

CerPE 15:0;O2/14:1

C31H63N2O6P (590.4424)


   

CerPE 15:1;O2/14:0

CerPE 15:1;O2/14:0

C31H63N2O6P (590.4424)


   

CerPE 16:1;O2/13:0

CerPE 16:1;O2/13:0

C31H63N2O6P (590.4424)


   

CerPE 17:1;O2/12:0

CerPE 17:1;O2/12:0

C31H63N2O6P (590.4424)


   

CerPE 18:1;O2/11:0

CerPE 18:1;O2/11:0

C31H63N2O6P (590.4424)


   

CerPE 19:1;O2/10:0

CerPE 19:1;O2/10:0

C31H63N2O6P (590.4424)


   

CerPE 29:1;O2

CerPE 29:1;O2

C31H63N2O6P (590.4424)


   

SM 14:1;O2/12:0

SM 14:1;O2/12:0

C31H63N2O6P (590.4424)


   

SM 15:1;O2/11:0

SM 15:1;O2/11:0

C31H63N2O6P (590.4424)


   

SM 16:1;O2/10:0

SM 16:1;O2/10:0

C31H63N2O6P (590.4424)


   

SM 26:1;O2

SM 26:1;O2

C31H63N2O6P (590.4424)


   

ST 29:1;O;GlcA

ST 29:1;O;GlcA

C35H58O7 (590.4182)


   

ST 29:2;O2;Hex

ST 29:2;O2;Hex

C35H58O7 (590.4182)


   

(1s,3ar,5ar,5br,7ar,9s,11ar,11br,13as,13br)-1-isopropyl-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(1s,3ar,5ar,5br,7ar,9s,11ar,11br,13as,13br)-1-isopropyl-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)


   

(2r,3r,4r,5r)-2-{[(1s,2s,3as,3br,4s,7s,9as,9bs,11as)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-[(2s)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

(2r,3r,4r,5r)-2-{[(1s,2s,3as,3br,4s,7s,9as,9bs,11as)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-[(2s)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


   

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)


   

19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(4-hydroxyphenyl)propanoate

19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(4-hydroxyphenyl)propanoate

C39H58O4 (590.4335)


   

21α-hydroxyserrat-14-en-3β-ylp-dihydrocoumarate

NA

C39H58O4 (590.4335)


{"Ingredient_id": "HBIN003545","Ingredient_name": "21\u03b1-hydroxyserrat-14-en-3\u03b2-ylp-dihydrocoumarate","Alias": "NA","Ingredient_formula": "C39H58O4","Ingredient_Smile": "CC1(C2CCC3(CC4=CCC5C(C(CCC5(C4CCC3C2(CCC1OC(=O)CCC6=CC=C(C=C6)O)C)C)O)(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10706","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r,3r,4s,5r,6r)-2-{[(1r,3ar,5as,7s,9as,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(1r,3ar,5as,7s,9as,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)


   

(1r,1's,5s,5's,8's,9s,9's,11'r,14r,14's,15s,16s,17'r,18'r,19r,21s)-5,5',7-trimethyl-20-oxa-7,7'-diazaspiro[heptacyclo[13.6.1.1⁵,⁹.0¹,¹².0⁴,¹¹.0¹⁴,¹⁶.0¹⁶,²¹]tricosane-19,12'-hexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane]-4(11),6',12-triene

(1r,1's,5s,5's,8's,9s,9's,11'r,14r,14's,15s,16s,17'r,18'r,19r,21s)-5,5',7-trimethyl-20-oxa-7,7'-diazaspiro[heptacyclo[13.6.1.1⁵,⁹.0¹,¹².0⁴,¹¹.0¹⁴,¹⁶.0¹⁶,²¹]tricosane-19,12'-hexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane]-4(11),6',12-triene

C41H54N2O (590.4236)


   

(2s,3r,4s,5r)-2-{[(3s,4s,4ar,6ar,6bs,8ar,9r,12as,14ar,14br)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5r)-2-{[(3s,4s,4ar,6ar,6bs,8ar,9r,12as,14ar,14br)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


   

(5e,7r,8s,9s,11e,13e,15s,16s)-16-[(2s,3r,4s)-4-[(2r,4r,5s,6r)-2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,5,7,9,11,15-hexamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

(5e,7r,8s,9s,11e,13e,15s,16s)-16-[(2s,3r,4s)-4-[(2r,4r,5s,6r)-2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,5,7,9,11,15-hexamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O7 (590.4182)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-hydroxy-5-isopropylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-hydroxy-5-isopropylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)


   

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)


   

(2s,3r,4s,5r)-2-{[(1r,3as,3br,4s,7s,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5r)-2-{[(1r,3as,3br,4s,7s,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


   

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-1-(2-hydroxypropan-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-1-(2-hydroxypropan-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)


   

16-[4-(2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-3,5,7,9,11,15-hexamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

16-[4-(2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-3,5,7,9,11,15-hexamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O7 (590.4182)


   

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-1-(2-hydroxypropan-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-1-(2-hydroxypropan-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)


   

(2s,3s,4s,5r,6r)-6-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H58O7 (590.4182)


   

(2s,3r,4s,5r)-2-{[(1r,2s,3as,3br,4s,7s,9as,9bs,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5r)-2-{[(1r,2s,3as,3br,4s,7s,9as,9bs,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


   

2-{[2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

2-{[2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


   

n-[14-(benzoyloxy)-15-[1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-9-en-6-yl]-2-methylpropanimidic acid

n-[14-(benzoyloxy)-15-[1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-9-en-6-yl]-2-methylpropanimidic acid

C37H54N2O4 (590.4083)


   

(2s,3r,4s,5s)-2-{[(3s,4s,4ar,6ar,6bs,8ar,9r,12as,14ar,14br)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5s)-2-{[(3s,4s,4ar,6ar,6bs,8ar,9r,12as,14ar,14br)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)


   

1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxyphenyl)prop-2-enoate

1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)


   

(3e,5e,7e,9e,11e,13e,15e,17e)-10,14,18,22-tetramethyl-5-[(1e,3e,5e,7e)-4,8,12-trimethyltrideca-1,3,5,7,11-pentaen-1-yl]tricosa-3,5,7,9,11,13,15,17,21-nonaen-2-one

(3e,5e,7e,9e,11e,13e,15e,17e)-10,14,18,22-tetramethyl-5-[(1e,3e,5e,7e)-4,8,12-trimethyltrideca-1,3,5,7,11-pentaen-1-yl]tricosa-3,5,7,9,11,13,15,17,21-nonaen-2-one

C43H58O (590.4487)


   

1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C35H58O7 (590.4182)


   

(3s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(4-hydroxyphenyl)propanoate

(3s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(4-hydroxyphenyl)propanoate

C39H58O4 (590.4335)


   

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)


   

1-(2-hydroxypropan-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

1-(2-hydroxypropan-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)


   

10,14,18,22-tetramethyl-5-[(1e,3e,5e,7e)-4,8,12-trimethyltrideca-1,3,5,7,11-pentaen-1-yl]tricosa-3,5,7,9,11,13,15,17,21-nonaen-2-one

10,14,18,22-tetramethyl-5-[(1e,3e,5e,7e)-4,8,12-trimethyltrideca-1,3,5,7,11-pentaen-1-yl]tricosa-3,5,7,9,11,13,15,17,21-nonaen-2-one

C43H58O (590.4487)


   

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C35H58O7 (590.4182)


   

1-[5-(2-ethoxy-1-hydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

1-[5-(2-ethoxy-1-hydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)


   

2-{[1-(5-hydroxy-5-isopropylhept-6-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-hydroxy-5-isopropylhept-6-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)


   

2-{[1-(5-ethyl-3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)


   

6-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

6-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H58O7 (590.4182)


   

n-[(1s,3r,6s,7s,8r,11s,12s,14r,15s,16r)-14-(benzoyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-9-en-6-yl]-2-methylpropanimidic acid

n-[(1s,3r,6s,7s,8r,11s,12s,14r,15s,16r)-14-(benzoyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-9-en-6-yl]-2-methylpropanimidic acid

C37H54N2O4 (590.4083)